1,282
Participants
Start Date
September 13, 2011
Primary Completion Date
June 10, 2015
Study Completion Date
October 1, 2019
Placebo SC
Placebo will be administered subcutaneously.
Placebo IV
Placebo will be administered as a single Intravenous infusion at week 0.
Ustekinumab 90 mg SC q8w
Ustekinumab 90 mg will be administered subcutaneously every 8 weeks (q8w) through Week 40.
Ustekinumab 130 mg IV
Ustekinumab 130 mg will be administered as a single intravenous infusion at week 0.
Ustekinumab 90 mg SC q12w
Ustekinumab 90 mg will be administered as subcutaneously every 12 weeks (q12w) through Week 40.
Tucson
La Jolla
Los Angeles
San Carlos
San Diego
Santa Monica
Lone Tree
New Haven
Boca Raton
Gainesville
Jacksonville
Naples
Weston
Winter Park
Atlanta
Decatur
Macon
Idaho Falls
Chicago
Evanston
Clive
Pratt
Crestview Hills
Lexington
Louisville
Baton Rouge
New Orleans
Baltimore
Chevy Chase
Towson
Boston
Worcester
Ann Arbor
Chesterfield
Detroit
Troy
Ypsilanti
Rochester
Jackson
Ocean Springs
Columbia
Lee's Summit
Urbana
Las Vegas
Lebanon
Marlton
Great Neck
New York
Poughkeepsie
Rochester
Chapel Hill
Charlotte
Raleigh
Cincinnati
Cleveland
Columbus
Mentor
Oklahoma City
Bend
Portland
Hershey
Philadelphia
Pittsburgh
Charleston
Columbia
North Charleston
Nashville
Austin
Grapevine
Houston
Tyler
Salt Lake City
Charlottesville
Chesapeake
Virginia Beach
Seattle
Madison
Adelaide
Bedford Park
Box Hill
Central Queensland M C
Concord
Garran
Liverpool
Malvern
Parkville
Innsbruck
Vienna
Brussels
Leuven
Liège
Goiânia
Porto Alegre
Rio de Janeiro
São Paulo
Pleven
Rousse
Sofia
Varna
Calgary
Edmonton
Vancouver
Brandon
Winnipeg
Hamilton
Kingston
London
Toronto
Montreal
Saskatoon
Rijeka
Zagreb
Hradec Králové
Ústí nad Labem
Herlev
Silkeborg
Lille
Marseille
Paris
Pessac
Reims
Rouen
Toulouse
Vandœuvre-lès-Nancy
Berlin
Erlangen
Frankfurt
Freiburg im Breisgau
Halle
Hamburg
Hanover
Haßloch
Heidelberg
Jena
Kiel
LÿNEBURG
Mannheim
München
Münster
Regensburg
Stade
Ulm
Békéscsaba
Budapest
Debrecen
Mosonmagyaróvár
Pécs
Szeksz Rd N/a
Székesfehérvár
Reykjavik
Dublin
Jerusalem
Kfar Saba
Petah Tikva
Ramat Gan
Rehovot
Tel Aviv
Tzrifin
Chikushino-shi
Fukuoka
Hachiōji
Hamamatsu
Hirosaki
Hiroshima
Kagoshima
Nishinomiya
Ohtsu
Osaka
Ōita
Sakura
Sapporo
Sendai
Suita-shi
Tokyo
Tsu
Uruma
Yokkaichi
Yokohama
Yokosuka
Amsterdam
Maastricht
Rotterdam
Auckland
Christchurch
Dunedin
Grafton
Hamilton
Hastings
Plenty
Elblag
Krakow
Lodz
Warsaw
Moscow
Novosibirsk
Saint Petersburg
Belgrade
Cape Town
Cape Town Western Cape
Pretoria
Somerset West
Daegu
Gyeonggi-do
Seoul
Madrid
Birmingham
Brighton
Bristol
Cambridge
Cardiff
Exeter
Gloucester
Liverpool
London
Manchester
Norwich
Nottinghamshirecc
Oxford
Shropshire
Southampton
Janssen Research & Development, LLC
INDUSTRY